TopMarketGainers Tuesday, 04/30/19 07:30:02 PM Re: None Post # of 454 VtV Therapeutics In Breakout zone today, up premarket. Highly speculative but has engaged our interest with volume and price spikes over the course of the last week. Up again today premarket and rumor mill is very active as is the case with many Bio-Pharm space.On the watchlist for breakout. Company Description vTv Therapeutics , Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC .